The United States government began a major overhaul of its effort to produce an Aids vaccine on Tuesday, stressing a return to basic scientific research after the failure of a key clinical trial last year. Government officials at a summit with Aids scientists pledged to prioritise spending on lab work and animal tests rather than expensive large-scale vaccine trials on humans.